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Abstract: For women who suffer from Alcohol Use Disorders (AUDs), the use of alcohol before
and/or during pregnancy may result in various birth complications, including miscarriage, stillbirth,
or preterm delivery. Thus, this study aimed to explore whether Alcohol Use Disorders (AUDs) are
associated with increased risk of adverse birth complications and outcomes. A total of 76,799 deliveries
between 2003 and 2013 in the Korean National Health Insurance Service National Sample Cohort
(NHIS-NSC) were analyzed. Women with an AUD diagnosis preceding delivery were identified as
individuals with alcohol dependence. A multivariate Cox proportional hazards model was used
to estimate the hazard ratio of adverse birth complications and outcomes associated with alcohol
dependence. Diagnosis of an AUD was associated with increased risk of adverse birth complications
(Hazard Ratio [HR]: 1.15, 95% CI: 1.01–1.31, p = 0.0302). This was especially the case for women
whose AUD diagnosis was in the same year as their delivery (HR: 1.53, 95% CI: 1.24–1.88, p < 0.0001).
AUDs were associated with increased risk of adverse birth outcomes, especially when prevalent in
the same year as a woman’s delivery. Our study confirms that the monitoring of expecting women
with a diagnosis of alcohol-related problems may be useful in preventing adverse birth complications.
Keywords: preterm birth; prenatal alcohol exposure; birth complications
1. Introduction
During the COVID-19 pandemic, alcohol consumption has been increasing as individuals
experience increased feelings of social estrangement, self-isolation, and a sense of loneliness [1].
For individuals with Alcohol Use Disorders (AUDs), this proposes a serious health-related problem as
chronic ethanol intake is associated with increased risk of bacterial and viral lung infections, including
COVID-19 [1], as well as multisystemic damage to the liver, heart, lungs, and body [2].
AUDs are a maladaptive pattern of heavy and harmful alcohol use that leads to various behavioral,
cognitive, and physiological phenomena, including a strong desire to drink, increased tolerance, and
physical withdrawal [3]. Globally, the World Health Organization (WHO) estimates that the harmful
use of alcohol is responsible for approximately 3 million deaths (5.3% of all deaths) each year [4]. In the
United States alone, AUDs are believed to affect an estimated 15 million people, including 9.2 million
men and 5.2 million women [5]. In South Korea, AUDs are believed to affect around 12.2% of adults
between 18 and 74 years old, including one in five men [6].
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For women who suffer from AUDs, the use of alcohol before and/or during pregnancy can result
in various pregnancy and birth complications, including miscarriage, stillbirth, preterm delivery, and
sudden infant death syndrome [7]. In one study of more than 3000 deliveries in the U.S., it was found
that for every unit increase in alcohol exposure, the risk of preterm delivery increased by 34-fold [8].
In a meta-analysis study of 231,808 pregnant women, those exposed to alcohol during pregnancy
had a greater risk of miscarriage (Odds Ratio [OR]: 1.19, 95% CI: 1.12–1.28), with each additional
alcoholic drink consumed during pregnancy being associated with a 6% increase in miscarriage risk
(OR: 1.06, 95% CI: 1.01–1.10) [8]. In an Ethiopian case-control study, mothers who drank alcohol during
pregnancy were 7.56 times more likely to have a stillbirth compared to abstainers (OR: 7.56, 95% CI:
1.68–34.04) [9].
Because alcohol may cause an angiogenic imbalance that affects lipid levels, inflammation, and
oxidative stress [10], drinking has also been associated with various clinical symptoms including
hypertension, proteinuria, and intrauterine growth restriction (IUGR). For example, in a study of 76,940
pregnant women in Japan, alcohol consumption during pregnancy was associated with significantly
higher odds of hypertensive disorders of pregnancy (OR: 3.98, 95% CI: 1.33–11.9), and placental accrete
(OR: 3.10, 95% CI: 1.69–5.44) [11]. In another study of pregnant women exposed to alcohol and tobacco
in Spain, the odds of IUGR increased by 22-fold, while the odds of small gestational age (SGA) increased
by 33-fold [12].
While many published reports have focused on an association between alcohol consumption
during pregnancy and such outcomes, few studies have focused on the association between a diagnosis
of alcohol addiction preceding pregnancy and subsequent consequences. Despite the fact that the
risk for alcohol use during pregnancy increases if the mother used and/or abused alcohol before
her pregnancy [13], few studies have found a link between drinking before conception and adverse
outcomes. Recently, one study found that parental binge drinking before conception may be associated
with a baby’s congenital heart defects [14], possibly because alcohol exposure affects the DNA in
developing sperm [15]. Another study claimed that alcohol intake before and during pregnancy is not
associated with infant motor development, and is only slightly associated with mean infant weight,
length, and head circumference at birth [16,17]. Because such studies are still new, there is no evidence
concerning the effects of a previous alcohol diagnosis on adverse birth outcomes, especially for a
nationwide population-based cohort.
Thus, this study aimed to examine the association between Alcohol Use Disorders (AUDs) and
the risk of adverse birth complications and outcomes using nationwide cohort data.
2. Materials and Methods
The data used in this study were obtained from the National Health Insurance Service National
Sample Cohort (NHIS-NSC) in Korea for the years 2002 to 2013. These data were constructed with the
sole purpose of providing public health researchers and policy-makers with representative, useful
information regarding Korean citizens’ utilization of health insurance and health examinations [18].
To construct the cohort, a representative sample cohort of 1,109,938 participants, representative of 2.2%
of the Korean population, was selected using systematic stratified random sampling with proportional
allocation of 1476 strata constructed based on age, sex, insurance eligibility status, and income [18].
Within each stratum, systematic sampling was conducted after sorting population data by the value of
total annual medical expenses, and drawing stratum samples iteratively until an absolute percentage
error of less than 5% was reached. During the follow-up period, a representative sample of newborns
was added annually, and all deceased or emigrated participants were excluded [18,19]. The final
population was followed for 11 years, during which a representative sample of newborns was added
annually, and all deceased or emigrated participants were excluded [18].
For the identification of pregnancy, we employed the International Classification of Diseases,
Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis codes Z32.1, Z33, Z34.00, Z34.80, Z34.90,
Z35, and O30, as seen in a previous study using the same dataset [19]. Incidence and risk of adverse
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birth complications (gestational hypertension, gestational diabetes, premature rupture of membranes
(PROM), placenta previa, abruption placentae, postpartum hemorrhage, meconium stained amniotic
fluid, fetal asphyxia, preterm birth, low birth weight, intrauterine growth restriction (IUGR) and
outcomes (spontaneous/threatened/missed abortions, miscarriage) were identified using ICD-10 codes
shown in the Supplementary Material Table S1. For accuracy purposes, only the first pregnancy of all
women in our dataset was examined.
For the identification of AUDs, we employed the International Classification of Diseases, Tenth
Revision, Clinical Modification (ICD-10-CM) diagnosis codes E24.4 (alcohol-induced pseudo-Cushing’s
syndrome), F10 (mental and behavioural disorders due to use of alcohol), G31.2 (degeneration
of nervous system due to alcohol), G62.1 (alcoholic polyneuropathy), G72.1 (alcoholic myopathy),
I42.6 (alcoholic cardiomyopathy), K29.2 (alcoholic gastritis), K70 (alcoholic liver disease), K85.2
(alcohol-induced acute pancreatitis), K86.0 (alcohol-induced chronic pancreatitis), as seen in a previous
study of alcohol use disorders [20].
We controlled for numerous patient-related covariates when analyzing the association between
alcoholism and adverse birth outcomes. Such variables included age of delivery, income, insurance
coverage, employment status, region, and year of diagnosis.
Age was divided into six 5 year groups (<20, 20–24, 25–29, 30–34, 35–39, ≥40) to reflect any
differences in the association between alcoholism and adverse outcomes by maternal age at delivery.
Insurance coverage was categorized into three groups: insurance (regional), insurance (corporate),
and Medical Aid. Based on the criteria of South Korea’s National Health Insurance (NHI) system,
individuals who are self-employed are covered by regional insurance, while individuals employed by
a company are covered by employer-based corporate insurance. Medical aid beneficiaries consist of all
those who have an income below the government-defined poverty threshold or a disability which
enables them to receive free inpatient and outpatient care through the government.
Region was divided into three categories according to population density: metropolitan
(Seoul, Gyeong-gido), city (Busan, Daegu, Incheon, Gwangju, Daejeon, Ulsan), and other
(Gangwondo, Chungcheongbukdo, Chungcheongnamdo, Jeollabukdo, Jeollanamdo, Gyeongsangbukdo,
Gyeongsangnamdo, Jeju Island).
We first examined the frequencies and percentages of each categorical variable at each patient’s
baseline and performed χ2 tests to examine the distribution for adverse birth complications and
outcomes according to each variable. Subsequently, we performed survival analyses using a Cox
proportional hazards model to examine the factors significantly associated with adverse pregnancy
outcomes. Cases with an event of birth complication or abortion were coded as 1, and all other cases
were coded as 0. The follow-up period in the study was from 1 January 2003 to 31 December 2013 with
the length of survival recorded in days. The HR and 95% confidence interval (CI) were computed from
the Cox proportional hazard model, and statistical significance was determined by a two-tailed test
with a p-value of 0.05 as the threshold. All statistical analyses were performed using SAS software,
version 9.4 (SAS Institute, Cary, NC, USA).
All methods were performed in accordance with relevant guidelines and regulations.
All experimental protocols were approved by the Institutional Review Board of Yonsei University’s
Health System (Y-2019-0174). The need for informed consent was waived since the NHIS-NSC provides
anonymous cohort data to researchers for scholarly use.
3. Results
This Table 1 presents the general characteristics of the study population. Of 76,799 women with
confirmed pregnancies during our study period, 1211 (1.57%) were in the AUD group, and 75,588
(98.43%) were in the control group. Among those with AUDs, 19.7% had adverse outcomes, compared
to 15.2% in the control group. Women with AUD diagnosis in the same year as their delivery had the
highest prevalence of adverse birth outcomes (24.3%), while women with no AUD diagnosis had the
lowest prevalence of adverse birth outcomes (15.2%).
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Table 1. General Characteristics of Deliveries and Adverse Pregnancy Outcome by AUD Diagnosis &
Diagnosis Proximity to Delivery.
Variables Total Deliveries
None Adverse Outcomes p-Value
n % n %
Alcohol Use Disorder (AUD) Diagnosis
None 75,588 64,130 84.8 11,458 15.2 <0.0001
Yes 1211 972 80.3 239 19.7
AUD Diagnosis Proximity to
Delivery
Same year as delivery 370 280 75.7 90 24.3 <0.0001
1 year before delivery 208 170 81.7 38 18.3
2 years before delivery 146 120 82.2 26 17.8
≥3 years before delivery 487 402 82.5 85 17.5
None 75,588 64,130 84.8 11,458 15.2
Age at Delivery
<20 842 794 94.3 48 5.7 <0.0001
20–24 6924 6223 89.9 701 10.1
25–29 29,745 25,313 85.1 4,432 14.9
30–34 28,604 23,816 83.3 4,788 16.7
35–39 8483 7020 82.8 1463 17.2
≥40 2201 1936 88.0 265 12.0
Income
Low 9439 8088 85.7 1351 14.3 0.0012
Medium 45,588 38,696 84.9 6892 15.1
High 21,772 18,318 84.1 3454 15.9
Employment Status
Unemployed 48,447 41,333 85.3 7114 14.7 <0.0001
Employed 28,352 23,769 83.8 4583 16.2
Medical Insurance
Insurance Coverage (Regional) 23,828 20,553 86.3 3275 13.7 <0.0001
Insurance Coverage (Corporate) 52,674 44,280 84.1 8394 15.9
Medical Aid 297 269 90.6 28 9.4
Disability
None 76,373 64,736 84.8 11,637 15.2 <0.0001
Moderate 317 266 83.9 51 16.1
Severe 109 100 91.7 9 8.3
Number of Births
1 7304 6814 93.3 490 6.7 <0.0001
2 3413 3038 89.0 375 11.0
3 2549 2141 84.0 408 16.0
≥4 63,533 53,109 83.6 10,424 16.4
Twin Birth Status
Single Birth 75,468 64,096 84.9 11,372 15.1 <0.0001
Twin Birth 1331 1006 75.6 325 24.4
Region
Metropolitan 35,844 30,076 83.9 5768 16.1 <0.0001
City 19,265 16,433 85.3 2832 14.7
Other 21,690 18,593 85.7 3097 14.3
Year of Diagnosis
2003 14,311 12,890 90.1 1421 9.9 <0.0001
2004 9127 7937 87.0 1190 13.0
2005 7975 6927 86.9 1048 13.1
2006 7069 6069 85.9 1000 14.1
2007 7018 5953 84.8 1065 15.2
2008 5719 4702 82.2 1017 17.8
2009 5100 4209 82.5 891 17.5
2010 5486 4398 80.2 1088 19.8
2011 5313 4246 79.9 1067 20.1
2012 4972 3865 77.7 1107 22.3
2013 4709 3906 82.9 803 17.1
76,799 65,102 84.8 11,697 15.2
Table 2 presents the results of the Cox proportional hazards model examining the association
between AUD diagnoses, AUD diagnosis proximity to delivery, and adverse pregnancy outcomes.
Women with a diagnosis of AUDs had increased risk (HR: 1.15, 95% CI: 1.01–1.31, p = 0.0302) of adverse
birth outcomes, especially if her AUD diagnosis was made in the same year as her delivery (HR:
1.53, 95% CI: 1.24–1.88, p < 0.0001). Age at delivery was also significantly associated with increased
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adverse birth outcomes: compared to the 20–24 years’ age group, women who gave birth in the 25–29
age group (HR: 1.41, 95% CI: 1.30–1.53, p < 0.0001), 30–34 age group (HR: 1.61, 95% CI: 1.48–1.74,
p < 0.0001), 35–39 age group (HR: 1.73, 95% CI: 1.58–1.89, p < 0.0001), and ≥40 age group (HR: 1.40,
95% CI: 1.21–1.61, p < 0.0001) had increased odds of adverse birth outcomes.





Alcohol Use Disorder (AUD) Diagnosis
None 1.00 - -
Yes 1.15 1.01 1.31 0.0302
AUD Diagnosis Proximity to Delivery
Same year as delivery 1.53 1.24 1.88 <0.0001
1 year before delivery 1.17 0.85 1.60 0.3461
2 years before delivery 0.99 0.67 1.46 0.9644
≥3 years before delivery 0.95 0.76 1.17 0.6142
None 1.00 - -
Age at Delivery
<20 0.58 0.43 0.77 0.0002
20–24 1.00 - -
25–29 1.41 1.30 1.53 <0.0001
30–34 1.61 1.48 1.74 <0.0001
35–39 1.73 1.58 1.89 <0.0001
≥40 1.40 1.21 1.61 <0.0001
Income
Low
Medium 0.98 0.91 1.04 0.4551
High 0.97 0.93 1.02 0.2268
Employment Status
Unemployed 1.00 - -
Employed 1.00 0.96 1.04 0.9079
Medical Insurance
Insurance Coverage (Regional) 1.00 - -
Insurance Coverage (Corporate) 1.06 1.01 1.10 0.0129
Medical Aid 0.79 0.54 1.15 0.2173
Disability
None 1.00 - -
Moderate 1.06 0.81 1.40 0.6789
Severe 0.60 0.31 1.16 0.1274
Number of Births
1 1.00 - -
2 1.80 1.57 2.06 <0.0001
3 2.80 2.46 3.20 <0.0001
≥4 2.70 2.46 2.96 <0.0001
Twin Birth Status
Single Birth 1.00 - -
Twin Birth 1.57 1.40 1.75 <0.0001
Region
Metropolitan 1.00 - -
City 0.93 0.89 0.97 0.0010
Other 0.92 0.88 0.96 0.0001
Year of Diagnosis
2003 1.00 - -
2004 1.33 1.23 1.43 <0.0001
2005 1.35 1.24 1.46 <0.0001
2006 1.44 1.33 1.56 <0.0001
2007 1.57 1.45 1.71 <0.0001
2008 1.91 1.76 2.07 <0.0001
2009 1.92 1.76 2.09 <0.0001
2010 2.31 2.14 2.51 <0.0001
2011 2.37 2.19 2.57 <0.0001
2012 2.75 2.53 2.97 <0.0001
2013 3.59 3.29 3.93 <0.0001
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Working with corporate insurance coverage also had increased risk of adverse birth outcomes
(HR: 1.06, 95% CI: 1.01–1.10, p = 0.0129) compared to women with regional insurance coverage, as did
women who had already given birth 2 times (HR: 1.80, 95% CI: 1.57–2.06, p < 0.0001), three times (HR:
2.80, 95% CI: 2.46–3.20, p < 0.0001), and four or more times (HR: 2.70, 95% CI: 2.46–2.96, p < 0.0001).
Women who gave twin births (HR: 1.57, 95% CI: 1.40–1.75, p < 0.0001) were at increased odds of
adverse birth outcomes compared to women who gave single births also.
On the contrary, compared to women living in metropolitan regions, women living in the city (HR:
0.93, 95% CI: 0.89–0.97, p = 0.0010) and other regions (HR: 0.92, 0.88–0.96, p = 0.0001) had decreased
risk of adverse birth outcomes.
Table 3 presents the results of the subgroup analysis of the association between types of adverse
birth outcomes and AUD diagnosis. AUD diagnosis was most strongly associated with increasing risk
of placenta previa (HR: 2.39, 95% CI: 0.97–5.91, p = 0.06) and Intrauterine Growth Restriction (HR: 1.77,
95% CI: 1.25–2.49, p = 0.00).
Table 3. Subgroup Analysis of Association between Types of Adverse Birth Outcomes and
AUD Diagnosis.







Gestational hypertension 1.00 0.62 0.09 4.50 0.64
Gestational diabetes 1.00 0.85 0.61 1.19 0.34
PROM * 1.00 0.95 0.55 1.64 0.85
Placenta previa 1.00 2.39 0.97 5.91 0.06
Abruptio placentae 1.00 -
Postpartum hemorrhage 1.00 1.48 0.76 2.86 0.25
Meconium stained amniotic fluid 1.00 -
Fetal asphyxia 1.00 -
Preterm birth 1.00 1.27 0.82 1.97 0.28
Low birth weight 1.00 -
IUGR ** 1.00 1.77 1.25 2.49 0.00
Birth Outcomes
Abortion 1.00 1.27 0.97 1.66 0.08
Miscarriage 1.00 1.14 0.95 1.37 0.15
* Premature rupture of membranes. ** Intrauterine Growth Restriction.
4. Discussion
Our findings show that AUD diagnosis is significantly associated with increased risk of adverse
birth outcomes, especially when the diagnosis is made in close proximity to delivery (same year as
delivery). To our knowledge, few studies to date have employed an ICD-10 diagnosis of AUDs as a
marker for predicting adverse birth outcomes, despite the fact that self-reported measures of alcohol
consumption during pregnancy are presumed to be highly unreliable.
Although instruments like the T-ACE/T-ACER-3, TWEAK, or Substance Use Risk Profile-Pregnancy
(SURP-P) have been empirically validated for use among pregnant women [21], it is undeniable that
self-reports are heavily influenced by recall bias. More importantly, because of the social stigmas
surrounding substance use during pregnancy, it is highly likely that such self-reports are underestimates
of actual alcohol consumption experience during pregnancy [22–24]. It should be noted that women
who report drinking during pregnancy, but fail to provide exact information on the amount of alcohol
they consumed during pregnancy, have the highest risk of stillbirths [7]. Such findings provide
evidence that self-reports of alcohol consumption during pregnancy are heavily dependent on social
desirability and stigmas.
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Until more research on biomarkers like meconium ethyl glucuronide (EtG) are developed to
detect alcohol consumption during pregnancy [24], employing ICD-10 diagnostic codes for AUDs may
provide accurate information regarding serious, alcohol-related problems among pregnant women.
While evidence has been conflicting regarding the association between alcohol diagnosis prior to
and during pregnancy and risk of adverse birth outcomes, one prospective cohort of 1303 pregnant
women in the United Kingdom found that intakes of more than 2 units of alcohol/week before
pregnancy, and in trimesters 1 and 2, were significantly associated with increased risk of babies with
lower birth weight, lower birth centile, and preterm birth compared to non-drinkers [17]. Likewise, in
a recent animal study in South Korea, alcohol consumption before or during pregnancy was associated
with increased risk of abnormal fetal development in ethanol-fed mice, who not only had significantly
decreased growth rates during the lactation period, but postnatal macrosomia [25,26]. Although these
results were not replicated in our study, we also saw an inverse pattern between AUD diagnosis
proximity to delivery and adverse birth outcomes. We were unable to control for various factors
like exact alcohol intake (units/week) during pregnancy, and continued alcohol consumption during
pregnancy due to the secondary nature of our data; however, controlling for these variables in future
studies may result in similar results to the existing body of literature.
Like previous studies, our study also found an association between high number of births and
the birth of twins with increased adverse birth outcomes. A high number of previous births has been
associated with poor pregnancy outcomes in a number of studies [27,28], and in vitro fertilization twins
are believed to have small but significantly increased risks of preterm birth and low birth weight [16].
Surprisingly, AUD diagnosis was not associated with increased risk of many individual birth
complications: AUD diagnosis was only associated with increased risk of intrauterine growth
retardation in our subgroup analysis. Many studies have explored the association between prenatal
alcohol exposure and intrauterine growth retardation [29–31], including a study of pregnant rats
in China, that found a significant association between alcohol consumption and reduced fetal
developmental indices, placental weight, and oxidative and anti-oxidative functioning [32].
The limitations of our study derive from the limited accuracy and reliability of the ICD-10
classification of alcoholism within our study population. Although it must be assumed that the
classifications were made by healthcare professionals fully aware and abiding of specific criteria for
maximum diagnostic reliability, chronic alcoholism is a difficult condition to diagnose. Furthermore,
diagnosing alcoholism among individuals with disability can be extremely challenging for clinicians;
heavy drinking associated with alcoholism can contribute to, or result from, several different psychiatric
syndromes ranging from depression to sociopathy and dementia, that make diagnosis confusing and
inaccurate [33].
Second, our study centered on the time until adverse birth outcome following year of diagnosis
(2003), which was around ten years. Therefore, during this time period, various confounding variables
will have influenced the patient’s risk of adverse birth outcomes, relative to medical advancements,
seasonal biological changes, and social, economic, and political factors. As of yet, there are not enough
previous studies with regard to a nationally representative population of Koreans when it comes to
measuring the impact of alcoholism and adverse birth outcomes. It is difficult to see whether the
figures we calculated are similar to that of the statistics found in previous studies for Koreans.
Also, while our study specifically focused on adverse birth outcomes that occur during birth
and mostly affect the mother, further studies should also attempt to examine the long-term and more
severe consequences of prenatal alcohol exposure on child development, i.e., fetal alcohol spectrum
disorders (FASDs). Prenatal alcohol exposure has been associated with a range of mental and/or
physical disabilities among individuals whose mothers consumed alcohol during pregnancy [34].
Previous studies have stated that consuming alcohol during pregnancy is one of the “most verified”
prenatal risk factors for impaired child development [24]. More studies are required to understand
how AUD diagnosis may affect the prevalence of such diseases as it is believed that FASDs occur
among one in 13 prenatally exposed infants [35].
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Lastly, while we assumed that alcohol consumption during pregnancy would be prevalent if an
AUD diagnosis was made in the same year as delivery, it is impossible to know whether or not this
was so. This was a limitation of our secondary data, but it is highly recommended that future studies
employ instruments like the T-ACE/T-ACER-3, TWEAK, or Substance Use Risk Profile-Pregnancy
(SURP-P) in simultaneity with AUD diagnoses, for a more accurate prediction of alcohol consumption
during pregnancy [21].
Despite these limitations, our study has a number of strengths. It is one of the first reports to address
the association between AUD diagnosis and adverse birth complications, while controlling for the
proximity between diagnosis time and birth. To our knowledge, no study in South Korea has attempted
to evaluate the association between alcohol consumption during pregnancy and adverse birth outcomes,
mostly because data on alcohol consumption during pregnancy are very rare, if not non-existent, in our
country as of now. Furthermore, our data consisted of a nationally representative sample of women
who were examined by medical professionals for the NHIS database. Most importantly, instead of
using retrospective self-reports of alcohol consumption during pregnancy, we measured the possibility
for alcohol-related problems during pregnancy through an ICD-10 diagnosis of AUDs, which allowed
for an accurate identification of expecting women with past/present alcohol-related problems.
5. Conclusions
Overall, such findings suggest that AUDs are significantly associated with increased risk of
adverse birth outcomes, especially when prevalent in the same year as a woman’s delivery. It is highly
recommended that healthcare professionals routinely ask all pregnant women about their alcohol
consumption, and pay special attention to women with a previous diagnosis of AUDs.
Validated behavioral interventions for AUDs in pregnancy include motivational enhancement
therapy and cognitive behavior therapies such as brief psychodynamic psychotherapy, interpersonal
therapy, educational interventions, and supportive counseling [21]. Pharmacological treatments with
medications like benzodiazepines and clomethiazole are not recommended for pregnant women
because of the risk of possible teratogenic effects [36]. Likewise, although naltrexone has shown
potential for use among pregnant, alcohol-dependent women, pharmacological treatments of any
kind should only be considered as a treatment option after a clinician has carefully evaluated the
implications of medication use on both the mother and fetus.
As AUDs are associated with neurobiological adaptations that reduce an individual’s cognitive
control, clinicians must be non-judgmental, non-directive, and private [37,38]. Empathy and mutual
respect are also important as previous research has found a positive association between these factors
and recovery from substance abuse among pregnant women [39]. Further research on preventive
measures, as well as pharmacological treatment of alcohol abuse and/or dependence among pregnant
women, is necessary to prevent adverse birth complications and outcomes among this population.
Lastly, healthcare professionals should always be supported by comprehensive, up-to-date information
on prenatal alcohol use and incorporate such information to prevent alcohol use among women before
they become pregnant [40].
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